Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eman G Youssef

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Diseases (Basel, Switzerland)|August 27, 2025
In Silico Design of a Multiepitope Vaccine Against Intestinal Pathogenic <i>Escherichia coli</i> Based on the 2011 German O104:H4 Outbreak Strain Using Reverse Vaccinology and an Immunoinformatic ApproachEman G Youssef, Khaled Elnesr, Amro Hanora
Journal of Fungi (Basel, Switzerland)|January 21, 2023
Protective Efficacy of Anti-Hyr1p Monoclonal Antibody against Systemic Candidiasis Due to Multi-Drug-Resistant <i>Candida auris</i>Shakti Singh, Ashley Barbarino, Eman G Youssef, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Diabetes and Immunosuppression Drive Distinct Patterns of <i>Candidozyma auris</i> Skin Colonization and Dissemination in MiceKaustav Das Gupta, Derek Quintanilla, Eman G Youssef, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2025
Efficacy assessments of EL219, a next-generation polyene antifungal, in immunosuppressed mice infected with drug-sensitive and drug-resistant <i>Aspergillus</i> isolatesEman G Youssef, Teclegiorgis Gebremariam, Yiyou Gu, et al.
Molecules (Basel, Switzerland)|December 21, 2017
Calli Essential Oils Synergize with Lawsone against Multidrug Resistant PathogensSameh S M Soliman, Abrar I Alsaadi, Eman G Youssef, et al.
Frontiers in Immunology|March 11, 2020
Monoclonal IgM Antibodies Targeting <i>Candida albicans</i> Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative BacteriaEman G Youssef, Lina Zhang, Sondus Alkhazraji, et al.
NPJ Vaccines|May 16, 2026
β-Glucan chitosan particle provides cross-protection against multi-drug-resistant Candida aurisShakti Singh, Ashley Barbarino, Eman G Youssef, et al.
Research Square|December 8, 2025
β-Glucan Chitosan Particle Provides Cross-Protection Against Multi-Drug- Resistant Candida aurisShakti Singh, Ashley Barbarino, Eman G Youssef, et al.
Scientific Reports|December 16, 2025
Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infectionsShakti Singh, Eman G Youssef, Ashley Barbarino, et al.
Research Square|September 15, 2025
Next-generation Candida albicans recombinant Als3p and Hyr1p dual antigen vaccine for invasive Candida infectionsShakti Singh, Eman G Youssef, Ashley Barbarino, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Diseases (Basel, Switzerland)|August 27, 2025
In Silico Design of a Multiepitope Vaccine Against Intestinal Pathogenic <i>Escherichia coli</i> Based on the 2011 German O104:H4 Outbreak Strain Using Reverse Vaccinology and an Immunoinformatic ApproachEman G Youssef, Khaled Elnesr, Amro Hanora
Journal of Fungi (Basel, Switzerland)|January 21, 2023
Protective Efficacy of Anti-Hyr1p Monoclonal Antibody against Systemic Candidiasis Due to Multi-Drug-Resistant <i>Candida auris</i>Shakti Singh, Ashley Barbarino, Eman G Youssef, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Diabetes and Immunosuppression Drive Distinct Patterns of <i>Candidozyma auris</i> Skin Colonization and Dissemination in MiceKaustav Das Gupta, Derek Quintanilla, Eman G Youssef, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2025
Efficacy assessments of EL219, a next-generation polyene antifungal, in immunosuppressed mice infected with drug-sensitive and drug-resistant <i>Aspergillus</i> isolatesEman G Youssef, Teclegiorgis Gebremariam, Yiyou Gu, et al.
Molecules (Basel, Switzerland)|December 21, 2017
Calli Essential Oils Synergize with Lawsone against Multidrug Resistant PathogensSameh S M Soliman, Abrar I Alsaadi, Eman G Youssef, et al.
Frontiers in Immunology|March 11, 2020
Monoclonal IgM Antibodies Targeting <i>Candida albicans</i> Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative BacteriaEman G Youssef, Lina Zhang, Sondus Alkhazraji, et al.
NPJ Vaccines|May 16, 2026
β-Glucan chitosan particle provides cross-protection against multi-drug-resistant Candida aurisShakti Singh, Ashley Barbarino, Eman G Youssef, et al.
Research Square|December 8, 2025
β-Glucan Chitosan Particle Provides Cross-Protection Against Multi-Drug- Resistant Candida aurisShakti Singh, Ashley Barbarino, Eman G Youssef, et al.
Scientific Reports|December 16, 2025
Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infectionsShakti Singh, Eman G Youssef, Ashley Barbarino, et al.
Research Square|September 15, 2025
Next-generation Candida albicans recombinant Als3p and Hyr1p dual antigen vaccine for invasive Candida infectionsShakti Singh, Eman G Youssef, Ashley Barbarino, et al.
Pageof 2